Case Reports in Neurology (Dec 2020)

NeuroAid II (MLC901) in Haemorrhagic Stroke

  • Chai-Hoon Nowel Tan,
  • David Choy,
  • Narayanaswamy Venketasubramanian

DOI
https://doi.org/10.1159/000508588
Journal volume & issue
Vol. 12, no. 1
pp. 212 – 217

Abstract

Read online

Stroke is a leading cause of death and disability. NeuroAid (MLC601), which originates from Traditional Chinese Medicine, comprises herbal and animal components, and has been shown to improve the functional status of patients after ischaemic stroke. The use of NeuroAid II (MLC901), which comprises only the herbal components of MLC601, in haemorrhagic stroke has not been previously reported. Our patient is a 63-year-old male with a significant stroke risk factor of hypertension. He developed visual field defect, aphasia, unilateral weakness, and hemisensory loss. CT scan showed a left thalamic haemorrhage. In addition to anti-hypertensive therapy and intensive rehabilitation, he was prescribed MLC901. Over a period of 6 months, he had significant improvements in his motor, sensory, and speech function. There were no adverse events, serial brain CT scans showed resolution of the haemorrhage. MLC901 may have a role in post-stroke recovery after intracranial haemorrhage.

Keywords